Pharmaceutical

Formation Bio secures $372m funds for AI-driven drug platform

Formation Bio has secured $372m in Series D funding to bolster its drug pipeline and expand its AI-driven drug development platform.

Jun 28, 2024 - 04:00
Formation Bio secures $372m funds for AI-driven drug platform
Formation Bio has secured $372m in Series D funding to bolster its drug pipeline and expand its AI-driven drug development platform.
Read the original article

Tags:

Previous Article

FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market

Next Article

US CDC recommends routine RSV vaccination for older adults

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Runimotamab by Genentech USA for Solid Tumor: Likelihoo...

Dec 22, 2023

Sanofi and Biovac partner to produce polio vaccines in Africa

Sanofi and Biovac partner to produce polio vaccines in ...

Jun 22, 2024

Biovac receives IFC loan for vaccine manufacturing in Africa

Biovac receives IFC loan for vaccine manufacturing in A...

Dec 16, 2023